Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Boussageon

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Revue Des Maladies Respiratoires|November 22, 2011
[Why isn't there more controversy on long-acting beta2-agonists in asthma?]R Boussageon
Diabetes & Metabolism|February 8, 2014
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?R Boussageon, F Gueyffier, C Cornu
Revue Des Maladies Respiratoires|December 4, 2012
[Are fixed combinations of inhaled corticosteroids and long-acting β2-agonists really harmless in asthmatics?]R Boussageon, L Laforest, E Van Ganse
L'Encephale|October 17, 2008
[Some reflexions about double blind]R Boussageon, F Gueyffier, A Moreau, et al.
Diabetes & Metabolism|May 11, 2015
Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?T Bejan-Angoulvant, C Cornu, P Archambault, et al.
Diabetes & Metabolism|June 1, 2019
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysisG Grenet, H H Le, T Bejan-Angoulvant, et al.
Diabetes & Metabolism|October 18, 2016
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trialsM B Rehman, B V Tudrej, J Soustre, et al.
Annales De Dermatologie Et De Venereologie|March 9, 2025
Systematic screening for skin cancers: Is it a good idea?X Humbert, J Dupouy, V Renard, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Revue Des Maladies Respiratoires|November 22, 2011
[Why isn't there more controversy on long-acting beta2-agonists in asthma?]R Boussageon
Diabetes & Metabolism|February 8, 2014
Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence?R Boussageon, F Gueyffier, C Cornu
Revue Des Maladies Respiratoires|December 4, 2012
[Are fixed combinations of inhaled corticosteroids and long-acting β2-agonists really harmless in asthmatics?]R Boussageon, L Laforest, E Van Ganse
L'Encephale|October 17, 2008
[Some reflexions about double blind]R Boussageon, F Gueyffier, A Moreau, et al.
Diabetes & Metabolism|May 11, 2015
Is HbA1c a valid surrogate for macrovascular and microvascular complications in type 2 diabetes?T Bejan-Angoulvant, C Cornu, P Archambault, et al.
Diabetes & Metabolism|June 1, 2019
Association between difference in blood pressure reduction and risk of cardiovascular events in a type 2 diabetes population: A meta-regression analysisG Grenet, H H Le, T Bejan-Angoulvant, et al.
Diabetes & Metabolism|October 18, 2016
Efficacy and safety of DPP-4 inhibitors in patients with type 2 diabetes: Meta-analysis of placebo-controlled randomized clinical trialsM B Rehman, B V Tudrej, J Soustre, et al.
Annales De Dermatologie Et De Venereologie|March 9, 2025
Systematic screening for skin cancers: Is it a good idea?X Humbert, J Dupouy, V Renard, et al.
Pageof 1